Skip to content

AKTX

Akari Therapeutics Plc

NASDAQ · Healthcare · Biotechnology · GB

$9.66
+18.09%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-16.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 16, 2026Bazemore Robert B · directorM-Exempt773$0.00
Oct 16, 2026Gaslightwala Abizer · director, officer: CEOA-Award174,000$7.90
Oct 16, 2026Gaslightwala Abizer · director, officer: CEOM-Exempt7,733$0.00
Oct 16, 2026Gaslightwala Abizer · director, officer: CEOM-Exempt19,333$0.00
Oct 16, 2026Bazemore Robert B · directorA-Award15,000$7.90
Oct 16, 2026Bazemore Robert B · directorA-Award45,000$7.90
Oct 16, 2026Bazemore Robert B · directorM-Exempt3,093$0.00
Oct 16, 2026Bazemore Robert B · directorA-Award4,677$7.90
Oct 16, 2026Prudo-Chlebosz Raymond · directorA-Award9,072$7.90
Oct 16, 2026Prudo-Chlebosz Raymond · directorA-Award3,240$7.90
Oct 16, 2026Prudo-Chlebosz Raymond · directorA-Award30,000$7.90
Oct 16, 2026Prudo-Chlebosz Raymond · directorA-Award15,000$7.90
Oct 16, 2026Huh Hoyoung · director, 10 percent owner: A-Award17,249$7.90
Oct 16, 2026Huh Hoyoung · director, 10 percent owner: A-Award6,160$7.90
Oct 16, 2026Huh Hoyoung · director, 10 percent owner: A-Award30,000$7.90
Oct 16, 2026Huh Hoyoung · director, 10 percent owner: A-Award15,000$7.90
Oct 16, 2026Patel Sandip I · directorA-Award12,100$7.90
Oct 16, 2026Patel Sandip I · directorA-Award4,313$7.90
Oct 16, 2026Patel Sandip I · directorM-Exempt3,866$0.00
Oct 16, 2026Patel Sandip I · directorM-Exempt6,186$0.00
Oct 16, 2026Patel Sandip I · directorA-Award45,000$7.90
Oct 16, 2026Patel Sandip I · directorA-Award15,000$7.90
Oct 16, 2026Bazemore Robert B · directorA-Award13,100$7.90
Oct 16, 2026Patel Samir Rashmikant · directorA-Award15,000$7.90
Oct 16, 2026Patel Samir Rashmikant · directorA-Award30,000$7.90
Oct 16, 2026Patel Samir Rashmikant · directorA-Award2,236$7.90
Oct 16, 2026Patel Samir Rashmikant · directorA-Award6,300$7.90
Oct 14, 2026Vat-Ho Vatnak · officer: Chief Business OfficerA-Award87,000$8.94
Oct 1, 2026Gaslightwala Abizer · director, officer: CEOA-Award6,430$9.72
Aug 19, 2026Farag Kameel D. · officer: Interim CFOA-Award1,728$7.52
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 1Reduced 6Sold out 3
FilerActionSharesFiled
MMCAP International Inc. SPCNew Position100,000Aug 14, 2026
ARMISTICE CAPITAL, LLCReduced38,922May 15, 2026
CRESSET ASSET MANAGEMENT, LLCReduced20,561May 15, 2026
Cresset Asset Management, LLCUnchanged20,561Aug 14, 2026
JANE STREET GROUP, LLCNew Position15,463Aug 14, 2026
HRT FINANCIAL LPNew Position13,745Aug 14, 2026
CITADEL ADVISORS LLCNew Position10,000Sep 2, 2026
IFP Advisors, IncReduced181Jul 20, 2026
SBI Securities Co., Ltd.Increased14Jul 23, 2026
Caitong International Asset Management Co., LtdNew Position8Aug 5, 2026
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONew Position7Aug 12, 2026
SBI SECURITIES CO., LTD.Reduced5Apr 28, 2026
MORGAN STANLEYReduced1May 15, 2026
Truvestments Capital LLCUnchanged1Aug 12, 2026
TRUVESTMENTS CAPITAL LLCReduced1May 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026